Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Montgomery Advertiser on MSN1d
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 Signals of dose-dependent reduction in active reservoir, and viral ...
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback